Pharmaceutical Manufacturing Market Size, Share & Growth Analysis By Molecule Type (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules)), By (In-house, Outsource), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other), By Route Of Administration (Oral, Topical, Parenteral, Inhalations, Other), By Prescription (Prescription Medicines, Over-the-counter (OTC) Medicines), By Age Group (Children & Adolescents, Adults, Geriatric), By Application (Cancer, Diabetes, Cardiovascular Diseases, Neurological Diseases, Respiratory Diseases, Other), By Sales Channel (Retail, Non-retail), And Regional Forecast, 2022-2028

Report Summary

Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pharmaceutical Manufacturing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.

Pharmaceutical Manufacturing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Key Research Highlights: Market Drivers

The Pharmaceutical Manufacturing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pharmaceutical Manufacturing products across developed and developing countries of the world.

Key Research Highlights: Market Restrains

Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pharmaceutical Manufacturing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pharmaceutical Manufacturing market.

Key Research Highlights: Trends

Increasing research and development spending on Pharmaceutical Manufacturing development has been the leading industry trend of Pharmaceutical Manufacturing market

The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.

Global Pharmaceutical Manufacturing Market Size, 2018-2028 (USD MILLION)

Market Segmentation

Key Market Players

• F. Hoffmann-La Roche Ltd.
• Novartis AG
• GlaxoSmithKline plc
• Pfizer, Inc.; Merck & Co., Inc.
• AstraZeneca
• Johnson & Johnson
• Sanofi SA
• Eli Lilly and Company
• AbbVie, Inc.
• Sun Pharmaceutical Industries Ltd.
• Novo Nordisk A/S
• Takeda Pharmaceuticals, Inc.
• Cipla Ltd.
• Bristol Myers Squibb Company
• Gilead Sciences, Inc.

By Molecule Type

• Biologics & Biosimilars (Large Molecules)
• Conventional Drugs (Small Molecules)

By Drug Development Type

• In-house
• Outsource

By Formulation

• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Other

By Routes of Administration

• Oral
• Topical
• Parenteral
• Inhalations
• Other Routes of Administration

By Prescription

• Prescription Medicines
• Over-the-counter (OTC) Medicines

By Age Group

• Children & Adolescents
• Adults
• Geriatric

By Application

• Cancer
• Diabetes
• Cardiovascular Diseases
• Neurological Diseases
• Respiratory Diseases
• Other

By Sales Channel

• Retail
• Non-retail

Key Benefits To The Stake Holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Table Of Contents

1 Methodology and Scope

1.1 Market segmentation & scope
1.2 Information Procurement

1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research

1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing

2 Executive Summary

3 Pharmaceutical Manufacturing Market Variables, Trends & Scope

3.1 Market Dynamics

3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator

3.2 Impact of COVID-19 Pandemic on Global Pharmaceutical Manufacturing Market

3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis

3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools

3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis

3.9 Key Company Ranking Analysis, 2020

4 Global Pharmaceutical Manufacturing Market Analysis and Forecast, By Type

4.1 Overview & Definition
4.2 Key Trends
4.3 Global Pharmaceutical Manufacturing Market Value (US$ Mn) Forecast, by Type (2019 – 2028)

4.2.1 Biologics & Biosimilars (Large Molecules)
4.2.2 Conventional Drugs (Small Molecules)
4.2.3 Other

4.4 Type Comparison Matrix
4.5 Global Pharmaceutical Manufacturing Market Attractiveness, By Type

5 Global Pharmaceutical Manufacturing Market Analysis and Forecast, By Application

5.1 Overview & Definition
5.2 Key Trends
5.3 Global Pharmaceutical Manufacturing Market Value (US$ Mn) Forecast, by Application (2019 – 2028)

5.3.1 Tablets
5.3.2 Capsules
5.3.3 Injectable
5.3.4 Sprays
5.3.5 Suspensions
5.3.6 Powders
5.3.7 Other Formulations

5.4 Application Comparison Matrix
5.5 Global Pharmaceutical Manufacturing Market Attractiveness, by Application

6 Global Pharmaceutical Manufacturing Market Analysis and Forecast, By Region

6.1 Overview & Definition
6.2 Key Trends
6.3 Global Pharmaceutical Manufacturing Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa

7 Global Pharmaceutical Manufacturing Market Attractiveness, by Region

8 North America Pharmaceutical Manufacturing Market Analysis and Forecast

8.1 Key Findings
8.2 North America Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

8.2.1 Biologics & Biosimilars (Large Molecules)
8.2.2 Conventional Drugs (Small Molecules)
8.2.3 Other

8.3 North America Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

8.3.1 Tablets
8.3.2 Capsules
8.3.3 Injectable
8.3.4 Sprays
8.3.5 Suspensions
8.3.6 Powders
8.3.7 Other Formulations

8.4 North America Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America

8.5 North America Pharmaceutical Manufacturing Market Attractiveness Analysis

8.5.1 By Type
8.5.2 By Application
8.5.3 By Country

9 Europe Pharmaceutical Manufacturing Market Analysis and Forecast

9.1 Key Findings
9.2 Europe Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

9.2.1 Biologics & Biosimilars (Large Molecules)
9.2.2 Conventional Drugs (Small Molecules)
9.2.3 Other

9.3 Europe Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

9.3.1 Tablets
9.3.2 Capsules
9.3.3 Injectable
9.3.4 Sprays
9.3.5 Suspensions
9.3.6 Powders
9.3.7 Other Formulations

9.4 Europe Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe

9.5 Europe Pharmaceutical Manufacturing Market Attractiveness Analysis

9.5.1 By Type
9.5.2 By Application
9.5.3 By Country

10 Asia Pacific Pharmaceutical Manufacturing Market Analysis and Forecast

10.1 Key Findings
10.2 Asia Pacific Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

10.2.1 Biologics & Biosimilars (Large Molecules)
10.2.2 Conventional Drugs (Small Molecules)
10.2.3 Other

10.3 Asia Pacific Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

10.3.1 Tablets
10.3.2 Capsules
10.3.3 Injectable
10.3.4 Sprays
10.3.5 Suspensions
10.3.6 Powders
10.3.7 Other Formulations

10.4 Asia Pacific Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC

10.5 Asia Pacific Pharmaceutical Manufacturing Market Attractiveness Analysis

10.5.1 By Type
10.5.2 By Application
10.5.3 By Country

11 Latin America Pharmaceutical Manufacturing Market Analysis and Forecast

11.1 Key Findings
11.2 Latin America Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)

11.2.1 Biologics & Biosimilars (Large Molecules)
11.2.2 Conventional Drugs (Small Molecules)
11.2.3 Other

11.3 Latin America Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

11.3.1 Tablets
11.3.2 Capsules
11.3.3 Injectable
11.3.4 Sprays
11.3.5 Suspensions
11.3.6 Powders
11.3.7 Other Formulations

11.4 Latin America Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

11.4.1 Brazil
11.4.2 Rest of Latin America China

11.5 Latin America Pharmaceutical Manufacturing Market Attractiveness Analysis

11.5.1 By Type
11.5.2 By Application
11.5.3 By Country

12 Middle East & Africa (MEA) Pharmaceutical Manufacturing Market Analysis and Forecast

12.1 Key Findings
12.2 Middle East & Africa (MEA) Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)

12.2.1 Biologics & Biosimilars (Large Molecules)
12.2.2 Conventional Drugs (Small Molecules)
12.2.3 Other

12.3 Middle East & Africa (MEA) Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)

12.3.1 Tablets
12.3.2 Capsules
12.3.3 Injectable
12.3.4 Sprays
12.3.5 Suspensions
12.3.6 Powders
12.3.7 Other Formulations

12.4 Middle East & Africa (MEA) Pharmaceutical Manufacturing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)

12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA

12.5 Middle East & Africa (MEA) Pharmaceutical Manufacturing Market Attractiveness Analysis

12.5.1 By Type
12.5.2 By Application
12.5.3 By Country

13 Competitive Landscape

13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles

13.3.1 F. Hoffmann-La Roche Ltd.; Novartis AG; GlaxoSmithKline plc; Pfizer

13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies

13.3.2 Inc.; Merck & Co.
13.3.3 Inc.; AstraZeneca; Johnson & Johnson; Sanofi SA; Eli Lilly and Company; AbbVie
13.3.4 Inc.; Sun Pharmaceutical Industries Ltd.; Novo Nordisk A/S; Takeda Pharmaceuticals
13.3.5 Inc.; Cipla Limited; Bristol Myers Squibb Company; Gilead Sciences
13.3.6 Inc.

14 Key Takeaways